Explore our clinically validated and ongoing research initiatives across Human and Animal medicine.
A randomized, open label, multicentered parallel group clinical study to evaluate the efficacy and safety of Joint Core® (Natural Egg Shell Membrane (Muttai Jow Complex®) 400 mg + Akbacore® Boswellia Serrata (30% AKBA) 90 mg + Cumincore® (Curcumin Extract 96%) 10 mg) compared to Jointace DN in Osteoarthritis patients.
A randomized, open label, multicenter parallel group clinical study comparing the relative bioavailability, safety and efficacy of Microcore NESC® with Calcium carbonate and Calcium citrate malate in osteopenic and osteoporotic patients.
Multicenter Randomized Evaluation of an Endoscopically Delivered Nano Eggshell Membrane–Derived Bioactive Peptide Scaffold for Hemostasis, Ulcer Healing, and Gastrointestinal Tissue Regeneration
Bone and joint care evaluation in adults canine population. Randomized, open-label, multicentered parallel group study.
Efficacy and safety evaluation in dental procedures. Randomized, open-label, multicentered parallel group clinical study.
"A Randomized, Open-Label, Multicenter, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Muttaijow Complex® in the Healing of Burn and Cut wounds
Microcore is proud of its strategic association and research collaboration with VGM Hospitals. This partnership enables us to conduct high-impact clinical research and translational studies, bridging the gap between innovative bioactives and real-world clinical applications.
Together, we are advancing mucosal healing strategies and regenerative therapies through evidence-based medicine and clinical excellence.
Evaluating Safety and Efficacy of Molecular Interlocked Joint Core vs Native Blends to Osteoarthritis Induced Rat Models. Validation of specialized therapeutic pathways for regenerative joint care.
Multiple molecular stability and efficacy studies are currently underway for our next-generation bioactive compounds.